Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healt...
Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Renin-angiotensin-aldosterone system inhibitor (RAASi) therapy has been shown to improve outcomes among patients with congestive heart failure, diabetes, or renal dysfunction. These patients are also at risk for the development of hyperkalemia (HK), often leading to down-titration and/or discontinuation of RAASi therapy. Patiromer is the first sodi...
Alternative Titles
Full title
Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2334187404
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2334187404
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0226844
